Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Psychiatr Res. 2017 Mar 20;91:130–138. doi: 10.1016/j.jpsychires.2017.03.012

Table 1.

Characteristics of participants in the discovery phase.

Fatigued (n = 15) Non-fatigued (n = 25) P Value
Age (years) 65.6 ± 1.9 66.0 ± 1.9 0.79
Race/ethnicity
 White 60.0% 72.0%
 Black/African American 26.7% 20.0% NA
 Asian 6.7% 4.0%
 Hispanic/Latino 6.7% 4.0%
BMI 31.5 ± 1.6 29.0 ± 1.2 0.13
Gleason Score 7.7 ± 0.3 7.5 ± 0.2 0.28
T stage
 T1c 28.6% 37.5% NA
 T2a-c 50.0% 58.3%
 T3a-c 21.4% 4.2%
HAM-D
 Baseline 0.9 ± 0.5 1.0 ± 0.4 0.92
 One year post-RT 2.2 ± 0.7 1.1 ± 0.4 0.05
PSA (ng/mL)
 Baseline 9.41 ± 6.86 7.38 ± 1.82 0.53
 One year post-RT 0.25 ± 0.17 0.19 ± 0.08 0.95

BMI: Body Mass Index; cm: centimeter; kg: kilogram; HAM-D: Hamilton Depression Rating Scale; PSA: prostate specific antigen; RT: radiotherapy. Values are mean ± standard error.